Publications
- HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity2009 | First Faculty of Medicine
- Polymer carriers for targeted drug delivery and controlled drug release2003 | First Faculty of Medicine
- HPMA copolymers, drug carriers, doxorubicin, drug targeting, drug delivery, cytotoxicity2003 | First Faculty of Medicine
- Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers2003 | First Faculty of Medicine
- Regulatory T cells and their prognostic value for head and neck oncology2009 | First Faculty of Medicine
- HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides.2009 | First Faculty of Medicine
- Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates2009 | First Faculty of Medicine
- HPMA-Anticancer Drug Conjugates2009 | First Faculty of Medicine
- Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics2009 | First Faculty of Medicine
- In Vivo Expansion of Activated Naive CD8(+) T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy2009 | First Faculty of Medicine
Loading network view...